EAPH / iBLISS Acquisition imminent for 100% ownership of ecig - vaporizer company with 15 M +/- per year in projected revenues. iBliss is considered a fast growing vaporizer and e-liquids manufacturing company also involved in the medical marijuana industry, possessing surging international sales projected to realistically reach and surpass $15,000,000 per year once its products are launched in new international markets and territories in conjunction with an adequate marketing campaign through agreements executed with local distributors. iBliss currently generates several millions of dollars in sales with healthy margins in excess of 40%. iBliss has had tremendous growth over the past 3 years of being in business, which includes sales throughout North America and recently adding several international markets in Europe, the Middle East and Russia. iBliss possesses in house manufacturing of its own line of e-liquids products in a certified and regulated laboratory which includes a laboratory for medical marijauana. iBliss's sales continue to grow with demand for vaporizers and e-liquids surging internationally. The company intends on launching medical marijuana and consumer health related products through its liquids for use in vaporizers, which expected to also result in substantial growth. Long Tran, CEO of iBliss, stated, "Negotiations have unfortunately taken longer than expected, but recent consensus on outstanding issues has made a closing very realistic and is anticipated within a week following the passing of documentation between attorneys."
EAPH / BAYER JV-- EAPH is pending approval of a third Sales and Distribution agreement with BAYER, a Big Pharma multi international company, that includes a upfront substantial payment for rights for marketing, sales and distribution of the EAPH licensed VS-Sense drug for Mexico and Latin America, and other future countries to come.
EAPH / GEDEON RICHTER JV – EAPH closed a second Sales & Distribution agreement with Gedeon Richter Big Pharma multi international pharma company, and in an agreement with EAPH, has invested in EAPH for the marketing, sales and distribution of EAPH licensed Gynofit, and also for a second EAPH licensed product: AL Sense for Mexico and other Latin American countries.
EAPH / WINDSOR PHARMA JV - Easton Pharmaceuticals Inc. closed a first Sales & Distribution agreement with Windsor Pharmaceuticals SA for three of its exclusively licensed Women's Health products for Central America and the Caribbean. Windsor Pharmaceuticals SA expects to launch in Q1, 2017, once streamlined regulatory submissions are granted, with sales growing to several million dollars by year three.
EAPH / MMJ JV’s in Canada, Jamaica, Argentinian, & US in various stages/agreements for acquisition and ownership of
MMJ grower license, sales and distribution of MMJ in Latin America and other international countries.
EAPH / AMFIL (AMFE) INVESTMENT- Amfil also owns a 10 M +/- per year revenue producing
company; “Snakes and Lattes” of Canada, and plans opening more locations internationally.
EAPH / BMV Acquisition in late stages for 100% ownership of BMV, their current distribution partner.
EAPH has secured interim financing and has closed on an interim financing facility for up to 2M with additional funding commitments, and EAPH is in the stages of employing additional Officers and Directors, and hiring Auditor/Financial Reporting Consultants for SEC quarterly reporting. EAPH is also acquiring, partnering, and developing new revenue producing joint ventures, with various RX and MMJ companies and products so as to create a network of worldwide marketing, distribution and sales of EAPH products, and their JV Partners products for RX and MMJ and their own Women’s Health Products, Gynofit, AL-Sense, VS-V Sense, EAPH Cancer Drugs, EAPH Medical Marijuana products, along with EAPH Ecig Products that are being worked into the Big Pharma pipeline deals, for worldwide marketing, distribution and sales, that will create many revenue streams for EAPH and there are other future JV in the works. EAPH is LONG and STRONG !!!!!!!!
AI
